References
- O’Leary PA, Kierland RR. Pyoderma faciale. Arch Dermatol Syphilol. 1940;41:451–462.
- Plewig G, Jansen T, Kligman AM. Pyoderma faciale: a review and report of 20 additional cases: is it rosacea? Arch Dermatol. 1992;128:1611–1617.
- Woo Y, Lim J, Cho D, et al. Rosacea: molecular mechanisms and management of a chronic cutaneous inflammatory condition. IJMS. 2016;17:1562–1584.
- Walsh RK, Endicott AA, Shinkai K. Diagnosis and treatment of rosacea fulminans: a comprehensive review. Am J Clin Dermatol. 2018;19:79–86.
- Jarrett R, Gonsalves R, Anstey AV. Differing obstetric outcomes of rosacea fulminans in pregnancy: report of three cases with review of pathogenesis and management. Clin Exp Dermatol. 2010;35:888–891.
- De Morais e Silva FA, Bonassi M, Steiner D, et al. Rosacea fulminans in pregnancy with ocular perforation. J Dtsch Dermatol Ges. 2011;9:542–543.
- Ferahbas A, Utas S, Mistik S, et al. Rosacea fulminans in pregnancy: case report and review of the literature. Am J Clin Dermatol. 2006;7:141–144.
- Cisse M, Maruani A, Bré C, et al. Rosacea fulminans in the early course of a pregnancy by in vitro fertilization with embryo transfer. Ann Dermatol Vénéréol. 2008;135:675–678.
- Marks VJ, Briggaman RA. Pyoderma faciale: successful treatment with isotretinoin. J Am Acad Dermatol. 1987;17:1062–1063.
- Lewis VJ, Holme SA, Wright A, et al. Rosacea fulminans in pregnancy. Br J Dermatol. 2004;151:917–919.
- Fuentelsaz V, Ara M, Corredera C, et al. Rosacea fulminans in pregnancy: successful treatment with azithromycin. Clin Exp Dermatol. 2011;36:674–676.
- Markou AG, Alessandrini V, Muray JM, et al. Rosacea fulminans during pregnancy. Clin Exp Obstet Gynecol. 2017;44:157–159.
- Demir O, Tas IS, Gunay B, et al. A rare dermatologic disease in pregnancy: rosacea fulminans-case report and review of the literature. Open Access Maced J Med Sci. 2018;6:1438–1441.
- Sudy E. Pyoderma faciale: gram-negative recovery by means of needle aspiration. Cutis. 2002;69:261–264.
- Gavrilova M, Alonso V, Martin-Gorgojo A, et al. Eruption in a patient with Crohn disease. JAMA Dermatol. 2013;149:97–102.
- Razeghi S, Halvorson CR, Gaspari AA, et al. Successful treatment of localized pyoderma faciale in a patient with Crohn disease. Gastroenterol Hepatol. 2013;9:541–543.
- Smith LA, Meehan SA, Cohen DE. Rosacea fulminans with extrafacial lesions in an elderly man: successful treatment with subantimicrobial-dose doxycycline. J Drug Dermatol. 2014;13:763–765.
- Sanz-Motilva V, Martorell Calatayud A, Rivera R, et al. Rosacea fulminans: report of two cases. Rev Med Chil. 2012;140:637–639.
- Kim TG, Noh SM, Do JE, et al. Rosacea fulminans with ocular involvement. Br J Dermatol. 2010;163:877–879.
- Debroy Kidambi A, Tiffin NJ, Ramsay HM. Atypical rosacea in a male patient: case study. Dermatol Online J. 2016;22:1–19.
- Patterson CRS, Wilkinson JD, Lewis FM. Rosacea fulminans confined to the nose. J Eur Acad Dermatol Venereol. 2009;23:1101–1102.
- Jansen T, Plewig G. Rosacea: classification and treatment. J R Soc Med. 1997;90:144–150.
- Schmitz S, Zouboulis CC. Pyoderma faciale (rosacea fulminans) assoziiert mit Colitis ulcerosa. H + G Z Hautkrank. 1995;70:939–940.
- Mori R, Matsushima S, Honda T, et al. Chronic superficial pyoderma of the face: an unusual male case of rosacea fulminans. J Dermatol. 2005;32:189–192.
- Jansen T, Romiti R, Kreuter A, et al. Rosacea fulminans triggered by high-dose vitamins B6 and B12. J Eur Acad Dermatol Venereol. 2001;15:484–485.
- Richard M, Seneschal J, Taïeb A. Azathioprine-induced rosacea. J Eur Acad Dermatol Venereol. 2017;31:e310–e311.
- Jensen SL, Holmes R. Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy. J Drugs Dermatol. 2003;2:554–556.
- Bettoli V, Mantovani L, Boccia S, et al. Rosacea fulminans related to pegylated interferon alpha-2b and ribavirin therapy. Acta Derm Venereol. 2006;86:258–259.
- Jansen T, Plewig G, Kligman AM. Diagnosis and treatment of rosacea fulminans. Dermatology (Basel). 1994;188:251–254.
- Jansen T, Plewig G. An historical note on pyoderma faciale. Br J Dermatol. 1993;129:594–596.
- Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78:148–155.
- Veraldi S, Scarabelli G, Rizzitelli G, et al. Treatment of rosacea fulminans with isotretinoin and topical alclometasone dipropionate. Eur J Dermatol. 1996;6:94–96.
- Bormann G, Gaber G, Fischer M, et al. Dapsone in rosacea fulminans. J Eur Acad Dermatol Venereol. 2001;15:465–467.
- Ormond P, Rogers S. Case 3. Pyoderma faciale (PF) (rosacea fulminans). Clin Exp Dermatol. 2003;28:107–108.
- Liu T-J, Lai C-S, Chen W-C, et al. A case of rosacea fulminans responsive to combination treatment with dapsone, doxycycline, and topical tacrolimus. Dermatol Sin. 2009;27:117–121.